라파스

214260KOSDAQ기타 화학제품 제조업

47.8 / 100

Reference Date: 2026-04-13

Financial Score10.5 / 40

News Sentiment21.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Declined 5.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Raphas specializes in the research, development, manufacturing, and sales of patches using dissolvable microneedles technology. Leveraging its proprietary DEN technology, the company produces microneedles at room temperature without heat or UV exposure, enabling applications in sensitive bio-pharmaceuticals. Currently focused on the cosmetics market, Raphas plans to expand into pharmaceuticals, vaccines, and medical devices, with ongoing collaborations with Serum Institute and Boehringer Ingelheim for vaccine and therapeutic patch development.

Number of Employees

103people

Average Salary

49.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 18.384.0Point

PBR

2.84Industry Average 1.370.0Point

2.1x industry avg (risky)

ROE

-15.21Industry Average 4.550.0Point

Well below industry avg

Debt Ratio

10.91Industry Average 8.132.0Point

Higher than industry avg (caution)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.6% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲13.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -19.2% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
라파스, 3월 감사 시즌뚫고 조기 제출… 매출 309억 '사상 최대'
라파스는 3월 감사 시즌에 앞서 감사보고서를 조기 제출하여 회계 리스크를 해소하고, 매출 309억원을 기록하며 사상 최대 본업 성장세를 공식화했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 9,760Won52-week high 21,15052-week low 9,320

1-month return2.0Point

1m -5.52% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-30
Neutral정기주주총회결과2026-03-30
Neutral[기재정정]의결권대리행사권유참고서류2026-03-23
Neutral[기재정정]주주총회소집공고2026-03-20
Neutral사업보고서 (2025.12)2026-03-20